SORRENTO THERAPEUTICS, INC.

Company Information

Company Name
SORRENTO THERAPEUTICS, INC.
Address
6042 CORNERSTONE CT, STE B
SAN DIEGO, CA, 92121-4746
Phone
n/a
URL
http://www.sorrentotherapeutics.com
DUNS
832545805
Number of Employees
65
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$224,823.00
1
STTR Phase I
$2,607,606.00
5
STTR Phase II
$1,997,627.00
1
Chart code to be here

Award List

  1. A vaccine against Clostridium difficile infections

    Amount: $598,689.00

    DESCRIPTION (provided by applicant): In this proposal we lay out a comprehensive research plan to evaluate our vaccination strategies targeting Clostridium difficile to prevent or treat infections. W ...

    STTR Phase I 2011 Department of Health and Human Services
  2. Evaluation of Staphylococcus aureus agr-based Quorum Sensing as Vaccine Candidate

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): In this proposal we lay out a comprehensive research plan to evaluate our passive vaccination strategies targeting Staphylococcus aureus/MRSA to prevent or treat ...

    STTR Phase I 2010 Department of Health and Human Services
  3. Human monoclonal antibodies for prevention of S. aureus infections

    Amount: $597,832.00

    DESCRIPTION (provided by applicant): Using mouse monoclonal antibodies (mAbs) raised against the mediators of quorum sensing (QS), the Auto-Inducing Peptides (AIPs), researchers at The Scripps Researc ...

    STTR Phase I 2012 Department of Health and Human Services
  4. Human Anti-WISP1 Antibodies for Treatment of Idiopathic Pulmonary Fbrosis

    Amount: $224,823.00

    DESCRIPTION (provided by applicant): New anti-fibrotic drugs are needed to treat Idiopathic Pulmonary Fibrosis (IPF). IPF is a progressive, chronically debilitating clinical syndrome with unknown etio ...

    SBIR Phase I 2014 Department of Health and Human Services
  5. Targeting of Myc-Max dimerization for the treatment of cancer

    Amount: $224,550.00

    DESCRIPTION (provided by applicant): Myc is a key transcriptional regulator due to its critical role in many fundamental cellular processes, such as cell cycle progression and cell growth. Therefore, ...

    STTR Phase I 2014 Department of Health and Human Services
  6. Anti-Pseudomonas Immunotherapy and Targeted Drug Delivery

    Amount: $586,535.00

    DESCRIPTION (provided by applicant): Antibody therapy for serious bacterial infections using polyclonal immune antitoxin or anti-capsule horse serum actually predates small molecule antibiotic use. Ho ...

    STTR Phase I 2014 Department of Health and Human Services
  7. Human monoclonal antibodies for prevention of S. aureus infections

    Amount: $1,997,627.00

    DESCRIPTION (provided by applicant): Using mouse monoclonal antibodies (mAbs) raised against the mediators of quorum sensing (QS), the Auto-Inducing Peptides (AIPs), researchers at The Scripps Researc ...

    STTR Phase II 2014 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government